Ethylhexyl Methoxycinnamate Cream
Detoxifying Day Cream Rich
Inspira:cosmetics Gmbh
Human Otc Drug
NDC 70493-521Ethylhexyl Methoxycinnamate Cream also known as Detoxifying Day Cream Rich is a human otc drug labeled by 'Inspira:cosmetics Gmbh'. National Drug Code (NDC) number for Ethylhexyl Methoxycinnamate Cream is 70493-521. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in Ethylhexyl Methoxycinnamate Cream drug includes Octinoxate - 2 g/50mL . The currest status of Ethylhexyl Methoxycinnamate Cream drug is Active.
Drug Information:
| Drug NDC: | 70493-521 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Ethylhexyl Methoxycinnamate Cream |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Detoxifying Day Cream Rich |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Inspira:cosmetics Gmbh |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Cream |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | OCTINOXATE - 2 g/50mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 01 Feb, 2016 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 10 May, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part352 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | inspira:cosmetics GmbH
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 4251059300696
|
| UPC stands for Universal Product Code. |
| UNII: | 4Y5P7MUD51
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 70493-521-02 | 1 JAR in 1 BOX (70493-521-02) / 50 mL in 1 JAR (70493-521-01) | 01 Feb, 2016 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Product Elements:
Ethylhexyl methoxycinnamate cream detoxifying day cream rich octinoxate octinoxate butylene glycol glycerin cetostearyl alcohol phenoxyethanol sorbitan monooleate ethylhexyl triazone camellia japonica flower hyaluronate sodium caprylyl/capryl oligoglucoside egg phospholipids butylated hydroxytoluene hydrogenated coco-glycerides glyceryl stearate se pentylene glycol shea butter diethylamino hydroxybenzoyl hexyl benzoate leontopodium alpinum flowering top allantoin, (+)- bisabolol oxide b, (-)- thermus thermophilus lysate glyceryl caprylate polyisobutylene (1300 mw) sodium acrylate/sodium acryloyldimethyltaurate copolymer (4000000 mw) tocopherol tetrasodium glutamate diacetate citric acid monohydrate sodium citrate sodium benzoate sodium hydroxide sodium anisate geraniol potassium sorbate caprylic/capric/palmitic/stearic triglyceride glyceryl stearate citrate water isostearyl isostearate propylheptyl caprylate polyglyceryl-10 stearate propanediol hydrogenated polybutene (1300 mw) saccharide isomerate sodium levulinate ascorbyl palmitate
When Using:
Directions directions: every morning, after cleansing evenly spread a small amount of cream over your face, neck and the area above your neckline and gently rub it in.
Package Label Principal Display Panel:
Active ingredients information and purpose ethylhexyl methoxycinnamate cream for uv and ir protection rich day care cream providing uv and ir protection for stressed and dry skin. high-alpine edelweiss combats premature ageing and aggressive environmental influences, while a special active substance with a detoxifying effect purifies the skin and hyaluronic acid and pentavitintm* smoothe it. outside packaging